Healthcare
This sector includes biotechnology, pharmaceuticals, research services, home healthcare, hospitals, long-term-care facilities, and medical equipment and supplies. Also include pharmaceutical retailers and companies which provide health information services. Companies in this sector include AstraZeneca, Pfizer, and Roche Holding, Walgreens Boots Alliance, and Cerner Corp.
Market Cap
6.528T
Market Weight
10.90%
Industries
11
Companies
1205
Healthcare S&P 500 ^GSPC
Loading Chart for Healthcare
DELL

Day Return

Sector
1.15%
S&P 500
0.02%

YTD Return

Sector
3.13%
S&P 500
11.24%

1-Year Return

Sector
8.32%
S&P 500
26.17%

3-Year Return

Sector
5.06%
S&P 500
26.31%

5-Year Return

Sector
68.58%
S&P 500
90.66%

Note: Sector performance is calculated based on the previous closing price of all sector constituents

Industries in This Sector

Select an Industry for a Visual Breakdown

IndustryMarket WeightYTD Return
All Industries
100.00%
3.13%
Drug Manufacturers - General
34.07%
8.81%
Healthcare Plans
13.04%
-6.24%
Medical Devices
12.82%
4.06%
Diagnostics & Research
11.60%
4.72%
Biotechnology
11.56%
-2.86%
Medical Instruments & Supplies
6.65%
3.62%
Medical Care Facilities
2.95%
12.20%
Drug Manufacturers - Specialty & Generic
2.78%
-4.37%
Medical Distribution
2.30%
5.84%
Health Information Services
2.02%
2.70%
Pharmaceutical Retailers
0.21%
-40.58%

Note: Percentage % data on heatmap indicates Day Return

All Industries

Largest Companies in This Sector

Name
Last Price
1Y Target Est.
Market Weight
Market Cap
Day Change %
YTD Return
Avg. Analyst Rating
807.86 859.23 11.98% 767.794B +0.05% +38.59%
Buy
503.68 567.48 7.23% 463.58B -0.88% -4.33%
Buy
144.38 172.72 5.42% 347.476B -1.76% -7.89%
Buy
126.09 142.18 4.98% 319.362B -2.63% +15.66%
Buy
155.34 183.11 4.28% 274.31B -1.10% +0.24%
Buy
572.57 624.17 3.41% 218.559B -1.97% +7.87%
Buy
258.71 271.39 2.99% 191.623B -1.55% +11.83%
Buy
101.95 125.59 2.77% 177.355B -1.92% -7.38%
Buy
300.19 318.55 2.51% 161.032B -1.85% +4.23%
Buy
28.30 31.46 2.50% 160.364B -2.01% -1.70%
Hold

Investing in the Healthcare Sector

Start Investing in the Healthcare Sector Through These ETFs and Mutual Funds

ETF Opportunities

Name
Last Price
Net Assets
Expense Ratio
YTD Return
142.67 37.936B 0.09% +4.61%
260.66 20.002B 0.10% +3.97%
134.08 6.991B 0.45% -1.30%
89.13 6.358B 0.35% -0.18%
55.61 5.241B 0.40% +3.04%

Mutual Fund Opportunities

Name
Last Price
Net Assets
Expense Ratio
YTD Return
212.85 45.706B 0.29% +1.79%
89.75 45.706B 0.29% +1.79%
130.42 20.002B 0.10% +3.99%
92.26 14.487B 0.80% +4.70%
91.99 14.487B 0.80% +4.65%

Healthcare Research

Discover the Latest Analyst and Technical Research for This Sector

  • Analyst Report: The Cooper Companies, Inc.

    The Cooper Companies is one of the largest eye care companies in the U.S. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business and is composed of a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and clariti, Cooper controls roughly a quarter of the U.S. contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women’s care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the U.S., and controls 17% of the U.S. IUD market.

    Rating
    Price Target
     
  • Analyst Report: Green Thumb Industries Inc.

    Green Thumb Industries is headquartered in Chicago, Illinois, and produces and sells medicinal and recreational cannabis through wholesale and retail channels in the United States. It has a presence in 14 states and operates 92 cannabis stores under the brand Rise. GTI is focusing its expansion on limited license states with large populations, and it does not currently export into the global medical market due to U.S. federal prohibition. It offers multiple products under a portfolio of cannabis consumer packaged goods brands, including &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles, and RYTHM.

    Rating
    Price Target
     
  • Weekly Stock List

    Vickers Stock Research, a subsidiary of Argus Research Group, tracks and analyzes insider trading and institutional stock ownership trends. Form 13-Fs, which institutions must file to report their holdings, are due 45 days after the end of calendar quarters, and have now come in from 1Q24. We like to review the 13Fs of the major activist investors, including Carl Icahn, Trian Fund Management, Jana Partners, and ValueAct Holdings, among others, to determine their core holdings and new purchases. Activist investing has evolved in recent years and is now less about generating a short-term return on an underpriced stock and more about achieving long-term returns through an active management/investor partnership. Activists have made progress in the past year with high-profile investments into blue-chip companies such as Fedex and Union Pacific. According to Vickers, here are recent new purchases and key holdings of activist investors and other high-profile money managers such as Warren Buffet of Berkshire Hathaway and Ken Griffin of Citadel Advisors LLC.

     
  • Analyst Report: Boston Scientific Corp.

    Based in Marlborough, Massachusetts, Boston Scientific is a developer, manufacturer, and marketer of medical devices used in a range of interventional medical specialties, including interventional cardiology, peripheral interventions, vascular surgery, electrophysiology, oncology, endoscopy, urology, gynecology, and neuromodulation. The company is a component of the S&P 500.

    Rating
    Price Target
     

From the Community

Healthcare News